OVID

Welcome to the Brand page for “OVID”, which is offered here for In the statement, the following class is updated per the board order dated 11/29/18: class 42.;pharmaceutical product evaluation * for the treatment of rare neurological diseases and disorders * ; pharmaceutical products development * for the treatment of rare neurological diseases and disorders * ; pharmaceutical research and development * for the treatment of rare neurological diseases and disorders *;.

Its status is currently believed to be active. Its class is unavailable. “OVID” is believed to be currently owned by “Ovid Therapeutics, Inc.”